New 2024 Guidelines on Managing Liver Injury from Targeted Therapies and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
The treatment of hepatocellular carcinoma (HCC) has seen revolutionary advancements with the introduction of molecular targeted therapies and immune checkpoint ...
